Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP254967.RAe7dtO_owPk6JUq8Y-9P8HauT8X832akhFaJZ2n3bDvg130_assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254967.RAe7dtO_owPk6JUq8Y-9P8HauT8X832akhFaJZ2n3bDvg130_provenance.
• NP254972.RAXndgT2xeCd32qNylUB40WvUz6WCZK1ox-TGiFUHGIas130_assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254972.RAXndgT2xeCd32qNylUB40WvUz6WCZK1ox-TGiFUHGIas130_provenance.
• NP254968.RAHXwp7yfSRif0B9DYmAR2T7Mor1qU1lX7sLo6anyEnUs130_assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254968.RAHXwp7yfSRif0B9DYmAR2T7Mor1qU1lX7sLo6anyEnUs130_provenance.
• NP254971.RA19aLw5gV6mFCbwhtDcLHcDINxz9Vh15nmStPYxKXI9I130_assertion description "[Plasma samples from healthy men, from healthy female users and nonusers of oral contraceptives, and from heterozygous and homozygous male and female carriers of the factor V Leiden mutation (some of whom used oral contraceptives) were tested for their sensitivity to activated protein C by means of a new activated protein C resistance test developed in our laboratory.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254971.RA19aLw5gV6mFCbwhtDcLHcDINxz9Vh15nmStPYxKXI9I130_provenance.